Meyka Pro banner
Sera Prognostics, Inc.

Sera Prognostics, Inc. (SERA) Stock Overview

Explore Sera Prognostics, Inc.’s financial performance, market position, analyst ratings, and future outlook.

SERANASDAQ
HealthcareMedical - Diagnostics & Research
$2.00
$0.07(3.63%)
U.S. Market opens in 13h 59m

Sera Prognostics, Inc. (SERA)

Meyka AI Score

Z

Key Financials

Market Cap74.9M
P/E Ratio-3.06
EPS (TTM)$-0.65
ROE-0.41%
Fundamental Analysis

AI Price Forecasts

1 Month$1.67
3 Months$4.17
1 Year Target$3.88

SERA Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Sera Prognostics, Inc. (NASDAQ: SERA) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Sera Prognostics, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of SERA on the NASDAQ shows an RSI of 48.44, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $3.88 for the NASDAQ listing.

Key metrics behind Sera Prognostics, Inc.'s NASDAQ-traded stock include a P/E ratio of -3.06 and a market capitalization of 74.9M. Combined with our AI analysis, these give both institutional and retail investors a clear view of SERA on the NASDAQ.

Price Performance (NASDAQ: SERA)

1-Day Change
1.55%
5-Day Change
-6.22%
1-Month Change
-6.22%
3-Month Change
4.26%
6-Month Change
-15.52%
Year-to-Date (YTD) Change
-33.56%
1-Year Change
-20.00%
3-Year Change
-23.44%
5-Year Change
-84.75%
All-Time (Max) Change
-83.53%

Contact Information

801 990 0520
2749 East Parleys Way, Salt Lake City, UT, 84109

Company Facts

630 Employees
IPO DateJul 15, 2021
CountryUS
Actively Trading

Frequently Asked Questions